CIK 0001091596 · Non-accelerated filer<br>Smaller reporting company
Nuo Therapeutics, Inc.
Sign in to watch- Ticker
- AURX
- Exchange
- OTC
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 233011702
- Phone
- 832-236-9060
- Business address
- 8285 EL RIO, SUITE 190, HOUSTON, TX, 77054
- Former names
- Nuo Therapeutics, Inc, CYTOMEDIX INC, AUTOLOGOUS WOUND THERAPY INC, AUTOLOGOUS WOUND TRERAPY INC
- Open-market buys, last 90 days
- $9,539
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$9,539. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-09-18 | SHEEDY CHARLES E 10% owner | Purchase | +125,000 | $0.75 | $94K | 11,437,500 |
| 2024-07-17 | WINZER C ERIC Director | Grant or award · Option to Purchase Common Stock | +40,000 | $0.33 | $13K | 40,000 |
| 2024-07-17 | Pittman Scott M. Director | Grant or award · Option to Purchase Common Stock | +40,000 | $0.33 | $13K | 40,000 |
| 2024-07-17 | Mintz Paul Director | Grant or award · Option to Purchase Common Stock | +25,000 | $0.33 | $8K | 25,000 |
| 2024-05-20 | SHEEDY CHARLES E 10% owner | Purchase | +100,000 | $0.75 | $75K | 11,312,500 |
| 2024-05-20 | CLAUSEN PETER CSO/COO | Grant or award | +15,000 | $0.75 | $11K | 586,201 |
| 2024-05-20 | Pittman Scott M. Director | Grant or award | +135,000 | $0.75 | $101K | 5,178,345 |
| 2023-12-19 | SHEEDY CHARLES E 10% owner | Purchase | +150,000 | $0.50 | $75K | 11,212,500 |
| 2023-12-19 | CLAUSEN PETER CSO/COO | Grant or award | +20,000 | $0.50 | $10K | 571,201 |
| 2023-12-19 | Pittman Scott M. Director | Grant or award | +600,000 | $0.50 | $300K | 5,043,345 |
| 2023-08-01 | SHEEDY CHARLES E 10% owner | Purchase | +62,500 | $2.00 | $125K | 11,062,500 |
| 2023-08-01 | CLAUSEN PETER CSO/COO | Grant or award | +25,000 | $2.00 | $50K | 551,201 |
| 2023-08-01 | Pittman Scott M. Director | Grant or award | +100,000 | $2.00 | $200K | 4,443,345 |
| 2022-11-09 | JORDEN DAVID EMERSON CEO/CFO | Sale | −30,000 | $1.50 | $45K | 2,107,858 |
| 2022-11-09 | JORDEN DAVID EMERSON CEO/CFO | Sale | −30,000 | $1.50 | $45K | 2,077,858 |
| 2022-11-09 | JORDEN DAVID EMERSON CEO/CFO | Sale | −27,000 | $1.50 | $41K | 2,050,858 |
| 2022-11-09 | JORDEN DAVID EMERSON CEO/CFO | Sale | −20,000 | $1.50 | $30K | 2,030,858 |
| 2022-11-09 | JORDEN DAVID EMERSON CEO/CFO | Sale | −20,000 | $1.50 | $30K | 2,010,858 |
| 2022-11-09 | JORDEN DAVID EMERSON CEO/CFO | Sale | −13,500 | $1.50 | $20K | 1,997,358 |
| 2022-11-09 | JORDEN DAVID EMERSON CEO/CFO | Sale | −10,000 | $1.50 | $15K | 1,987,358 |
Page 4 of 17 · 326 trades